On Monday, Relay Therapeutics Inc (NASDAQ: RLAY) was 5.25% up from the session before settling in for the closing price of $6.29. A 52-week range for RLAY has been $1.77 – $7.64.
A company in the Healthcare sector has dropped its sales by -23.05% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 25.89%. With a float of $131.71 million, this company’s outstanding shares have now reached $172.63 million.
Relay Therapeutics Inc (RLAY) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Relay Therapeutics Inc stocks. The insider ownership of Relay Therapeutics Inc is 24.01%, while institutional ownership is 74.66%. The most recent insider transaction that took place on Nov 03 ’25, was worth 434,511. In this transaction President and CEO of this company sold 62,073 shares at a rate of $7.00, taking the stock ownership to the 703,215 shares. Before that another transaction happened on Oct 29 ’25, when Company’s insider sold 21,394 for $7.50, making the entire transaction worth $160,455. This insider now owns 337,469 shares in total.
Relay Therapeutics Inc (RLAY) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.45 earnings per share (EPS) during the time that was better than consensus figure (set at -0.55) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.08% during the next five years compared to -23.05% drop over the previous five years of trading.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
You can see what Relay Therapeutics Inc (RLAY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 19.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 137.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.75, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.71 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
Let’s dig in a bit further. During the last 5-days, its volume was 2.3 million. That was better than the volume of 2.15 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 46.10%.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 77.90%, which indicates a significant increase from 39.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was higher than the 0.29 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.84, while its 200-day Moving Average is $3.97. However, in the short run, Relay Therapeutics Inc’s stock first resistance to watch stands at $6.88. Second resistance stands at $7.15. The third major resistance level sits at $7.50. If the price goes on to break the first support level at $6.26, it is likely to go to the next support level at $5.91. Assuming the price breaks the second support level, the third support level stands at $5.64.
Relay Therapeutics Inc (NASDAQ: RLAY) Key Stats
There are 173,322K outstanding shares of the company, which has a market capitalization of 1.15 billion. As of now, sales total 10,010 K while income totals -337,710 K. Its latest quarter income was 680 K while its last quarter net income were -70,380 K.
